Longitude Capital

Longitude Capital invests in biotechnology and medical technology companies, with a focus on de-risked assets with venture return potential within 3 to 5 years. It has developed a multi-stage strategy helping to mitigate risk, and targets companies that improve clinical outcomes, enhance quality of life and/or improve care delivery.